Learn how you can manage and alleviate your current side effects while actively working to prevent a relapse or secondary cancer using evidence-based, non-toxic therapies.
Click the orange button to the right to learn more.
Ducal Carcinoma In-situ (DCIS) is Not Breast Cancer-Consider Evidence-based, Non-Toxic Therapies to Reduce Your Risk of Breast Cancer The mission of PeopleBeatingCancer is to demystify cancer. I research
Continue readingReduce your Pre-Malignant DCIS from becoming Full-Blown Breast Cancer You’ve been diagnosed with Ductal Carcinoma In-Situ (DCIS). While some people will call this diagnosis breast cancer, it really
Continue readingThe finding may mean that (breast cancer patients) women with pain related to aromatase inhibitor use might stick to their meds longer if acupuncture eases their joint pain. Aromatase inhibitors are a
Continue readingThey did not just publish that the breast cancer cure rates were the same, but they published very in-depth cosmetic assessments Breast Cancer can be complicated. The two guiding principles of PeopleBeatingCancer
Continue readingA new study suggests that “an estimated 20 percent of breast cancer patients in the United States who receive radiation after they undergo breast-conserving surgery may not have their radiation treatments
Continue reading“When we compare our low-dose tamoxifen data with results from the… trials of tamoxifen given at 20 mg per day, we see comparable risk reduction and significantly reduced serious adverse events,
Continue readingFrom 2013 to 2015, keeping other factors constant, chemotherapy use (for breast cancer) was estimated to decline from 34.5% to 21.3%. A diagnosis of cancer is difficult, to say the least. However, an
Continue readingAnnual mammography in women aged 40-59 does not reduce mortality from breast cancer beyond that of physical examination or usual care when adjuvant therapy for breast cancer is freely available. No matter
Continue readingCases of DCIS have increased 5 fold between 1983 and 2003 in the United States due to the introduction of screening mammography.” DCIS Diagnosis: Confusion Over Whether This Is Cancer or Not “Women
Continue readingFor women who have early breast tumors (DCIS) surgically removed, a genetic test may help predict the odds of a recurrence, a new study says Receiving a diagnosis of Ductal Carcinoma In Situ (DCIS)
Continue reading“Breast cancer patients are more likely to experience a return and spread of their cancer within 18 months after a mastectomy or removal of the breast tumour along with healthy breast tissues.” I
Continue reading“Breast cancer screening was not associated with any reduction in the incidence of advanced cancer, and overdiagnosis of invasive tumors and ductal carcinoma in situ is a common problem…” Articles
Continue reading